Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Michael R. Bishop, MD, specializes in the diagnosis and treatment of lymphomas. In particular, he cares for patients with advanced hematologic malignancies that have not responded to first-line treatments. An expert in hematopoietic stem cell transplant (bone marrow transplantation) and cellular therapy. Dr. Bishop and his team are working to address the unique social, economic, physiological and biological issues that patients face while undergoing this treatment. Dr. Bishop's research focuses on the prevention and treatment of relapse after stem cell transplantation. He has served as the principal investigator on studies designed to prevent and treat disease recurrence after transplantation. Specifically, he works on ways to enhance immune effects of the transplanted cells against cancer. An active contributor to medical literature, Dr. Bishop has authored more than 250 peer-reviewed articles, in addition to more than 30 book chapters and two books on cancer treatment and research. Since 2001, Dr. Bishop has consistently been named one of the "Best Doctors in America" by Best Doctors, Inc. He previously served as a Senior Investigator and as the clinical head of stem cell transplantation for the National Cancer Institute at the National Institutes of Health. Dr. Bishop is a dedicated mentor, teaching residents and fellows in classroom, clinical and research settings. Many of his past trainees hold leadership roles in medical oncology and immunology at academic medical centers or at the National Cancer Institute in Bethesda, Maryland.